Trial Profile
Investigation of the Effect of Food and of Increased Gastric pH on the Relative Bioavailability of Deleobuvir Following Single Oral Administration in Healthy Caucasian and Japanese Subjects (an Open-label, Randomised, Four-way Crossover Study)
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs Deleobuvir (Primary) ; Omeprazole
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 14 May 2016 Status changed from completed to discontinued.
- 22 Jan 2014 Status has gone changed from active not recruiting to completed, according to ClinicalTrials.gov record.
- 21 Nov 2013 New trial record